Equity
BioNTech SE (BNTX) perpetual futures
BNTX perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade BNTXUSDT.
BioNTech SE is a biotechnology company developing immunotherapies for cancer and infectious diseases, including mRNA-based vaccines and CAR T-cell treatments.
Price chart
Use the left and right arrow keys to inspect points on the chart.
Trading data
Perpetual market activity
1/2 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
2 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
MEXC
BingXTradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kNo sufficient depth · 0 of 1 venues absorb $10k
No fresh book data: MEXC
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
BNTXTightest spread
BNTXHighest volume
BNTXFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 5h ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 5h ago
Charts: revenue, profit, cash flow & valuation
Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
BNTX-PERPFilings
PendingTranscripts
PendingCompany news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Analyst track record
How the analysts covering BNTX have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 139 | 478 |
| Analysts | 24 | 29 |
| Buy / hold / sell | 122 / 17 / 0 | 361 / 110 / 7 |
| Upgrades / downgrades / initiations | 2 / 2 / 1 | 9 / 4 / 10 |
| Price targets hit / missed | 8 / 125 (6%) | 30 / 403 (7%) |
| Avg. return after a rating (TipRanks) | -26.3% | -25.0% |
| Best / worst call | +8.2% / -46.5% | +13.9% / -47.7% |
After buy calls on this stock: median 21-day move +0.1% vs S&P 500 -1.0% (n = 349)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Daina GrayboschLeerink Partners53% hit rate on this stock · 15 targets measuredHoldtarget $113Feb 2, 2026
- Robert BurnsH.C. Wainwright45% hit rate on this stock · 29 targets measuredBuytarget $130Apr 27, 2026
- Emmanuel PapadakisDeutsche Bank7% hit rate on this stock · 14 targets measuredBuytarget $140Aug 26, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 28, 2026 | Terence FlynnMorgan Stanley | BuyReiterated | $115 | article ↗ |
| Sep 25, 2026 | Jeffrey WalchBernstein | HoldMaintained | $96.00 | article ↗ |
| Sep 24, 2026 | Mohit BansalWells Fargo | BuyMaintained | $140 | article ↗ |
| Sep 24, 2026 | Mohit BansalWells Fargo | BuyMaintained | $140 | |
| Sep 23, 2026 | John NewmanCanaccord Genuity | BuyMaintained | $136 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Oct 2, 2026 · 139 ratings
Frequently asked questions
Where can I trade BNTX perpetual futures?
BioNTech SE (BNTX) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade BNTX around the clock?
Yes. Unlike the underlying stock, BNTX perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on BNTX perpetuals?
Right now the BNTX perp funding rate is -14.8% annualized (venue median), ranging from -14.8% to -14.8% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the BNTX perp price compare to the BioNTech SE stock?
The venue-median BNTX perp mark is $96.9 versus a reference stock price of $96.9, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a BNTX perpetual future?
A BNTX perpetual is a derivative that tracks the price of BioNTech SE with no expiry date. It lets you take long or short exposure to BioNTech SE on crypto venues, around the clock.
What is BNTXUSDT perpetual?
BNTXUSDT is the symbol most crypto exchanges use for the BioNTech SE perpetual settled in USDT (Tether). It tracks the BNTX share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/bntx-perp"><img src="https://perpequities.com/badge/bntx-perp.svg" width="240" height="64" alt="BNTX perpetuals · perpequities.com" loading="lazy"></a>